Tin level requirements for multiple gated studies in humans: A new perspective
Stannous pyrophosphate (Sn-PYP) has been used for over a decade for in vivo and in vitro labeling of red blood cells with 99mTc. Literature references indicate minimum levels of stannous ion [Sn(II)] acceptable for successful labeling, based on in vitro experiments, to range from 140 to 400 ng/mL of...
Gespeichert in:
Veröffentlicht in: | International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology Nuclear medicine and biology, 1986, Vol.13 (6), p.642,645-643,645 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Stannous pyrophosphate (Sn-PYP) has been used for over a decade for
in vivo and
in vitro labeling of red blood cells with
99mTc. Literature references indicate minimum levels of stannous ion [Sn(II)] acceptable for successful labeling, based on
in vitro experiments, to range from 140 to 400 ng/mL of whole blood. Our study was undertaken in 200 patients using two different commercially available formulations of Sn-PYP in order to quantitate the Sn(II) levels required on an
in vivo basis to achieve consistently high quality labeling. |
---|---|
ISSN: | 0883-2897 |
DOI: | 10.1016/0883-2897(86)90040-1 |